Additionally, INI-1 mutations have been reported in sinonasal carcinoma, gastrointestinal stromal tumors (GIST), pancreatic cancer, and malignancies of the urologic tract (20–26). Here, SMARCB1 is linked to nasal cavity and paranasal sinus carcinoma.